单次肌肉注射 Nirsevimab 可降低出生后第一年平均风险婴儿因 RSV 而住院的可能性。

IF 3.8 3区医学 Q1 MEDICINE, GENERAL & INTERNAL

American family physician Pub Date : 2024-05-01

Mark H Ebell

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

Single Intramuscular Dose of Nirsevimab Reduces Likelihood of Hospitalization Due to RSV in Average-Risk Infants During First Year of Life.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

American family physician 医学-医学：内科

CiteScore

2.80

自引率

2.50%

发文量

368

审稿时长

4-8 weeks

期刊介绍： American Family Physician is a semimonthly, editorially independent, peer-reviewed journal of the American Academy of Family Physicians. AFP’s chief objective is to provide high-quality continuing medical education for more than 190,000 family physicians and other primary care clinicians. The editors prefer original articles from experienced clinicians who write succinct, evidence-based, authoritative clinical reviews that will assist family physicians in patient care. AFP considers only manuscripts that are original, have not been published previously, and are not under consideration for publication elsewhere. Articles that demonstrate a family medicine perspective on and approach to a common clinical condition are particularly desirable.